Our Next Event:

Post AASLD

The goal of this CME program is to learn more about current trends, management techniques, recent innovations, and research to treat a full range of liver conditions, including Fatty Liver/NASH, Hepatocellular Carcinoma, Cholestatic Diseases, and Liver Transplantation. The American Association for the Study of Liver Diseases (AASLD) is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. The AASLD fosters research that leads to improved treatment options for millions of liver disease patients. They advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies. Each November, the AASLD holds the Annual Liver Meeting to provide access and education to groundbreaking science, the exchange of ideas with leading clinicians and researchers, and network with peers.

*** Industry partners must have an exhibit or sponsorship to participate in the Community Liver Alliance programs and events.

Your support allows the Community Liver Alliance to continue to provide education, resources and support to the liver community we all serve.

For more information on ways to support and collaborate with the Community Liver Alliance, please contact Suzanna Masartis at Suzanna@communityliveralliance.org or 412-400-9343.

Register

Global Awareness. Local Impact.

CLA's mission is to promote disease awareness, prevention, education, advocacy, and research. Headquartered in Pittsburgh and with offices in Milwaukee, the Community Liver Alliance has grown to have a national presence while still holding true to a mission to invest in local communities and give voice to patients and providers.

Learn More

News & Information

Seniors

Improving Seniors Timely Access to Care

Improving Seniors Timely Access to Care H.R. 3107, Care Act of 2019 CLA cosponsored legislation that streamlined and standardized the Prior Authorization (PA) process under Medicare Advantage (MA). PA is

Read More »
November 17, 2019

Ask Congress to Support the LIVER Act

Ask Congress to Support the Liver Illness Visibility, Education, and Research (LIVER) Act What is the Liver Illness Visibility, Education, and Research (LIVER) Act?The LIVER Act is a public health

Read More »
November 17, 2021

Advocacy

Liver Disease Does Not Discriminate
There is 80 to 100 million people in the USA that have Fatty Liver Disease and most do not even know they have it. Liver Disease does not discriminate. It affects any age, social economics and race. Liver cancer incidence rates have more than tripled since 1980, while the death rates have more than doubled during this time.
COVID-19 Response
Ensure funding for COVID-19 and liver disease public health programs, research, vaccine dissemination; ensure that people living with liver disease are not disproportionately impacted and do not experience unnecessary or discriminatory health care or treatment disruptions.
Health Disparities
Address inequities in the care of people impacted by liver disease, especially the excess incidence rate of liver cancer in black men in America.
Liver Health Policy
Advance the U.S. NASH Action Plan, and ensure patients with liver disease perspectives are represented in relevant legislative packages: COVID-19, diabetes, and obesity.
Liver Health Regulations
Work with regulators to establish logical pathways to consistently approve therapies for liver diseases, particularly rare liver diseases.
Research Funding
Advocate for funding that ensures meaningful growth of vital liver disease research and the improving of liver health.
Transplant
Urgently respond to the inequities that impact organ transplantation; modernize the U.S. Organ Donation system, improve care for transplant patients, and increase the number of available organs.
Viral Hepatitis
Increase support for hepatitis programs and raise awareness of viral hepatitis; advocate for the elimination of viral hepatitis .
Value
Advance health care policies that reflect each person’s unique needs and drive access to personalized, patient-centric care.
Patient Access and Reimbursement
Support policy solutions that curb patients’ health care expenses; advocate for the smoothing and capping of out-of-pocket costs in Medicare Part D.
Previous
Next
Learn More
0
PEOPLE IN USA WITH LIVER DISEASE
0
PEOPLE IN USA WITH FATTY LIVER DISEASE
0 %
RISE IN LIVER CANCER SINCE 1980
Huber

Cindy Huber

Director of Operations, Donate Life Wisconsin
"CLA Is an amazing resource for patients and their families as well as the healthcare professionals who provide care…"

Upcoming Program & Events

thumbnail_candy
a5b522_bb2badba75194f0ca50fa9f4b1eb9bd3_mv2_d_5184_3456_s_4_2 (1)
a5b522_3be131b09ce34a6381cb85f997038b37_mv2_d_4000_3000_s_4_2
CLA Event 4
CLA Event 2
CLA Event 3
a5b522_600aab52d64b44e8bf3dabd99cdc0790_mv2
CLA Event 1
20220727_125343
Previous
Next

Events Search and Views Navigation

Event Views Navigation

Today

Post AASLD

Register Now: https://cvent.me/EZ31zo Program Overview The goal of the CME program is to learn more about current trends, management techniques, recent innovations, and research to treat a full range of […]

Pediatric Liver Disease Conference

The 2022 Pediatric Liver Conference Register Now: https://cvent.me/GNlOrX Registration deadline December 1st Are you a clinician or caregiver supporting a child with liver disease? Join us for a virtual conference as […]

Managing Patients with Fatty Liver and Metabolic Diseases

Virtual Liver Update Series 2022-2023 Register now: https://cvent.me/A9dQv0   Course Director William Hutson, MD WVU Medicine Section Chief & Professor, Gastroenterology & Hepatology, Medicine Professor & Section Chief, Gastroenterology & […]

You Make a Difference Award Event

Deadline for Submission is November 10th! At the Carnegie Science Center PointView Hall This award will select recipients to be recognized for their outstanding accomplishments going above and beyond supporting […]